Suzhou Novartis Pharma, a pharmaceutical enterprise invested and built by Novartis, one of the world's top five pharmaceutical groups, in China, was established in 2006 and is engaged in the production of patented protected active pharmaceutical ingredients. In December 2019, Suzhou Novartis Pharmaceutical was acquired by Zhejiang Jiuzhou Pharmaceutical and became Ribo (Suzhou) Pharmaceutical. As a long-term partner of Novartis / Ribo Pharmaceutical, Wellthinic Technology provides maintenance services, including process control and production process renovation and upgrade.
Solution Description:
The solution covers the automation system of the entire site. Combining a flexible system architecture and modular design, including three main production workshops, one pilot workshop, tank farms, solvent recovery, and other auxiliary workshops, it realizes efficient interconnection between the production control layer and the management layer. Through the transplantation of long-accumulated module functions and the replication of successful experiences, it integrates third party equipment using standard protocols. Based on the support of the GAMP5 validation guideline, it ensures that the system is flexible, stable, and compliant.
Implementation Effect:
The new drug launch cycle is shortened by 30%
The renovation and upgrade cycle is shortened by 30%
The production efficiency is increased by 35%
Follows the production specifications of pharmaceutical enterprises to ensure the integrity, standardization, replicability, and repeatability of the process
Meets the GMP requirements of the EU and FDA and follows the guidance of ISPE GAMP4 and GAMP5
Cooperative Projects and History:
2015, SCADA Project of Suzhou Novartis Pharma
2018, Rooster Automation Project of Suzhou Novartis Pharma
2018, EMS Expansion of the Pilot BA System and PAS of Suzhou Novartis Pharma
2020, C4 Automation Project of Suzhou Raybow Pharma
2023, DCS Project of Taizhou Raybow Tank Farm, and the PAS for Suzhou Novartis Pharma
2022, DCS Project of Suzhou Raybow Pilot Plant
2024, PEMS for Jiuzhou Pharmaceutical Taizhou Raybow Energy Management, and DCS Project for Workshop 8#
